​

SI-BONE (SIBN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SIBN Stock Forecast

SI-BONE stock forecast is as follows: an average price target of $18.50 (represents a 39.62% upside from SIBN’s last price of $13.25) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.

SIBN Price Target

The average price target for SI-BONE (SIBN) is $18.50 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $19.00 to $18.00. This represents a potential 39.62% upside from SIBN's last price of $13.25.

SIBN Analyst Ratings

Buy

According to 8 Wall Street analysts, SI-BONE's rating consensus is 'Buy'. The analyst rating breakdown for SIBN stock is 0 'Strong Buy' (0.00%), 6 'Buy' (75.00%), 2 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

SI-BONE Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 06, 2024Samuel BrodovskyTruist Financial$18.00$14.0428.21%35.85%
Aug 06, 2024David SaxonNeedham$19.00$14.3632.31%43.40%
Mar 28, 2024Matt O'BrienPiper Sandler$25.00$15.8258.03%88.68%
Jul 12, 2023David SaxonNeedham$32.00$26.9318.83%141.51%
Jan 06, 2023Morgan Stanley$18.00$12.5843.08%35.85%
Dec 20, 2022Truist Financial$17.00$11.7744.50%28.30%
May 16, 2022Drew RanieriMorgan Stanley$22.00$12.5076.00%66.04%

The latest SI-BONE stock forecast, released on Aug 06, 2024 by Samuel Brodovsky from Truist Financial, set a price target of $18.00, which represents a 28.21% increase from the stock price at the time of the forecast ($14.04), and a 35.85% increase from SIBN last price ($13.25).

SI-BONE Price Target by Period

1M3M12M
# Anlaysts--3
Avg Price Target--$20.67
Last Closing Price$13.25$13.25$13.25
Upside/Downside-100.00%-100.00%56.00%

In the current month, the average price target of SI-BONE stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to SI-BONE's last price of $13.25. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 03, 2024Piper SandlerOverweightOverweightHold
Aug 06, 2024NeedhamBuyBuyHold
May 07, 2024NeedhamUnderperformUnderperformHold
May 07, 2024Piper SandlerBuyBuyHold
May 07, 2024Bank of America SecuritiesNeutralNeutralHold
Mar 28, 2024Piper SandlerBuyBuyHold
Mar 28, 2024Piper SandlerOverweightInitialise
Feb 27, 2024Truist FinancialBuyBuyHold
Dec 22, 2023NeedhamBuyBuyHold
Nov 07, 2023Cantor FitzgeraldOverweightOverweightHold
Jul 12, 2023NeedhamBuyBuyHold
May 02, 2023Canaccord GenuityBuyBuyHold
Feb 28, 2023NeedhamBuyBuyHold
Jan 06, 2023Morgan StanleyOverweightOverweightHold
Apr 26, 2022Zacks Investment ResearchHoldUpgrade

SI-BONE's last stock rating was published by Piper Sandler on Oct 03, 2024. The company gave SIBN a "Overweight" rating, the same as its previous rate.

SI-BONE Financial Forecast

SI-BONE Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$34.01M$33.30M$32.71M$31.95M$26.43M$25.59M$22.44M$25.23M$22.29M$22.19M$20.44M$22.14M$20.37M$14.05M$16.82M$19.81M$16.18M
Avg Forecast$60.73M$55.73M$55.06M$54.21M$54.18M$47.76M$46.94M$44.69M$46.89M$40.49M$39.10M$36.49M$37.92M$32.38M$31.21M$29.17M$31.50M$26.43M$25.17M$21.87M$24.71M$22.49M$21.74M$18.93M$22.08M$16.51M$8.78M$17.87M$19.29M$16.27M
High Forecast$61.69M$56.61M$55.93M$55.07M$55.04M$48.51M$47.68M$45.44M$47.16M$40.49M$39.10M$36.49M$38.52M$32.38M$31.71M$29.63M$32.00M$26.43M$25.17M$21.87M$24.71M$22.49M$21.74M$18.93M$22.08M$16.51M$8.78M$17.87M$19.29M$16.27M
Low Forecast$60.12M$55.17M$54.51M$53.67M$53.64M$47.28M$46.47M$43.94M$46.73M$40.48M$39.10M$36.49M$37.54M$32.38M$30.90M$28.88M$31.19M$26.43M$25.17M$21.87M$24.71M$22.49M$21.74M$18.93M$22.08M$16.51M$8.78M$17.87M$19.29M$16.27M
# Analysts111111136322422211112226999955
Surprise %-------------1.05%1.07%1.12%1.01%1.00%1.02%1.03%1.02%0.99%1.02%1.08%1.00%1.23%1.60%0.94%1.03%0.99%

SI-BONE's average Quarter revenue forecast for Dec 23 based on 4 analysts is $37.92M, with a low forecast of $37.54M, and a high forecast of $38.52M. SIBN's average Quarter revenue forecast represents a 11.47% increase compared to the company's last Quarter revenue of $34.01M (Sep 23).

SI-BONE EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111136322422211112226999955
EBITDA-------------$-11.17M$-10.36M$-10.29M$-10.29M$-13.40M$-17.89M$-16.14M$-13.26M$-12.62M$-12.40M$-10.84M$-7.55M$-8.09M$-9.53M$-11.29M$-7.65M$-9.89M
Avg Forecast$-27.90M$-25.61M$-25.30M$-24.91M$-24.89M$-21.94M$-21.57M$-20.53M$-21.54M$-18.60M$-17.97M$-15.46M$-17.42M$-14.88M$-14.34M$-14.05M$-13.09M$-12.82M$-12.21M$-12.77M$-11.98M$-10.91M$-10.55M$-11.65M$-10.71M$-8.01M$-4.26M$-8.62M$-9.36M$-7.89M
High Forecast$-27.62M$-25.35M$-25.04M$-24.66M$-24.64M$-21.72M$-21.35M$-20.19M$-21.47M$-18.60M$-17.97M$-12.36M$-17.25M$-14.88M$-14.20M$-11.24M$-10.47M$-12.82M$-12.21M$-10.22M$-11.98M$-10.91M$-10.55M$-9.32M$-10.71M$-8.01M$-4.26M$-6.89M$-9.36M$-7.89M
Low Forecast$-28.34M$-26.01M$-25.70M$-25.30M$-25.29M$-22.29M$-21.91M$-20.88M$-21.67M$-18.60M$-17.97M$-18.55M$-17.70M$-14.88M$-14.57M$-16.86M$-15.71M$-12.82M$-12.21M$-15.33M$-11.98M$-10.91M$-10.55M$-13.98M$-10.71M$-8.01M$-4.26M$-10.34M$-9.36M$-7.89M
Surprise %-------------0.75%0.72%0.73%0.79%1.05%1.47%1.26%1.11%1.16%1.18%0.93%0.70%1.01%2.24%1.31%0.82%1.25%

undefined analysts predict SIBN's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than SI-BONE's previous annual EBITDA (undefined) of $NaN.

SI-BONE Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111136322422211112226999955
Net Income-------------$-10.02M$-11.21M$-10.12M$-11.06M$-14.75M$-19.14M$-17.95M$-15.02M$-15.87M$-13.98M$-12.24M$-10.09M$-9.47M$-12.47M$-12.77M$-9.71M$-11.31M
Avg Forecast$-4.22M$-5.03M$-5.66M$-6.66M$-4.94M$-5.96M$-6.85M$-8.05M$-6.22M$-9.97M$-11.55M$-16.66M$-11.60M$-14.29M$-16.53M$-15.14M$-16.67M$-19.58M$-20.23M$-13.77M$-15.96M$-17.24M$-16.44M$-13.16M$-12.48M$-16.00M$-26.41M$-9.75M$-14.40M$-15.39M
High Forecast$-4.16M$-4.96M$-5.59M$-6.57M$-4.87M$-5.88M$-6.76M$-6.13M$-5.05M$-9.84M$-11.40M$-13.33M$-10.80M$-14.10M$-16.32M$-12.11M$-16.45M$-19.58M$-20.23M$-11.01M$-15.96M$-17.24M$-16.44M$-10.53M$-12.48M$-16.00M$-26.41M$-7.80M$-14.40M$-15.39M
Low Forecast$-4.31M$-5.13M$-5.78M$-6.79M$-5.04M$-6.08M$-6.99M$-9.58M$-7.39M$-10.17M$-11.79M$-19.99M$-12.40M$-14.58M$-16.87M$-18.17M$-17.01M$-19.58M$-20.23M$-16.52M$-15.96M$-17.24M$-16.44M$-15.79M$-12.48M$-16.00M$-26.41M$-11.70M$-14.40M$-15.39M
Surprise %-------------0.70%0.68%0.67%0.66%0.75%0.95%1.30%0.94%0.92%0.85%0.93%0.81%0.59%0.47%1.31%0.67%0.73%

SI-BONE's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. SIBN's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

SI-BONE SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111136322422211112226999955
SG&A-------------$34.22M$35.29M$34.79M$34.68M$32.74M$36.52M$32.74M$32.74M$29.72M$29.64M$26.86M$25.31M$23.69M$19.91M$24.68M$24.47M$23.26M
Avg Forecast$75.58M$69.36M$68.52M$67.47M$67.43M$59.44M$58.42M$55.62M$58.36M$50.39M$48.67M$31.33M$47.19M$40.30M$38.85M$28.48M$39.21M$32.90M$31.33M$27.22M$30.75M$27.99M$27.06M$23.56M$27.48M$20.55M$10.93M$22.23M$24.00M$20.24M
High Forecast$76.78M$70.46M$69.61M$68.53M$68.49M$60.38M$59.34M$56.55M$58.70M$50.39M$48.67M$37.59M$47.94M$40.30M$39.46M$34.18M$39.83M$32.90M$31.33M$27.22M$30.75M$27.99M$27.06M$23.56M$27.48M$20.55M$10.93M$22.23M$24.00M$20.24M
Low Forecast$74.83M$68.67M$67.84M$66.79M$66.76M$58.85M$57.84M$54.69M$58.16M$50.38M$48.67M$25.06M$46.72M$40.30M$38.46M$22.78M$38.81M$32.90M$31.33M$27.22M$30.75M$27.99M$27.06M$23.56M$27.48M$20.55M$10.93M$22.23M$24.00M$20.24M
Surprise %-------------0.85%0.91%1.22%0.88%1.00%1.17%1.20%1.06%1.06%1.10%1.14%0.92%1.15%1.82%1.11%1.02%1.15%

SI-BONE's average Quarter SG&A projection for Dec 23 is $47.19M, based on 4 Wall Street analysts, with a range of $46.72M to $47.94M. The forecast indicates a 37.89% rise compared to SIBN last annual SG&A of $34.22M (Sep 23).

SI-BONE EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111136322422211112226999955
EPS-------------$-0.25$-0.30$-0.29$-0.32$-0.43$-0.56$-0.53$-0.45$-0.56$-0.45$-0.39$-0.32$-0.36$-0.52$-0.50$-0.39$-0.49
Avg Forecast$-0.10$-0.12$-0.14$-0.16$-0.12$-0.14$-0.16$-0.19$-0.15$-0.24$-0.28$-0.31$-0.28$-0.34$-0.40$-0.41$-0.40$-0.47$-0.49$-0.43$-0.39$-0.42$-0.40$-0.40$-0.30$-0.39$-0.64$-0.38$-0.35$-0.37
High Forecast$-0.10$-0.12$-0.13$-0.16$-0.12$-0.14$-0.16$-0.15$-0.12$-0.24$-0.27$-0.30$-0.26$-0.34$-0.39$-0.41$-0.39$-0.47$-0.49$-0.43$-0.39$-0.42$-0.40$-0.40$-0.30$-0.39$-0.64$-0.38$-0.35$-0.37
Low Forecast$-0.10$-0.12$-0.14$-0.16$-0.12$-0.15$-0.17$-0.23$-0.18$-0.24$-0.28$-0.32$-0.30$-0.35$-0.40$-0.42$-0.41$-0.47$-0.49$-0.43$-0.39$-0.42$-0.40$-0.40$-0.30$-0.39$-0.64$-0.38$-0.35$-0.37
Surprise %-------------0.73%0.76%0.70%0.80%0.91%1.14%1.24%1.16%1.34%1.13%0.98%1.06%0.93%0.81%1.30%1.12%1.32%

According to undefined Wall Street analysts, SI-BONE's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to SIBN previous annual EPS of $NaN (undefined).

SI-BONE Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
RPIDRapid Micro Biosystems$1.06$8.00654.72%Hold
LUNGPulmonx$6.13$13.00112.07%Buy
SGHTSight Sciences$3.62$7.50107.18%Hold
RXSTRxSight$38.04$70.1484.38%Buy
KIDSOrthoPediatrics$22.46$39.5075.87%Buy
CNMDCONMED$71.23$97.0036.18%Buy
OFIXOrthofix Medical$17.93$24.0033.85%
SIBNSI-BONE$13.84$18.5033.67%Buy
NPCENeuroPace$11.52$15.0030.21%Buy
IRMDIRadimed$53.00$60.0013.21%Buy
ITGRInteger$136.68$153.5012.31%Buy
ESTAEstablishment Labs$44.67$45.000.74%Buy
TCMDTactile Systems$17.82$16.00-10.21%Buy

SIBN Forecast FAQ

Is SI-BONE a good buy?

Yes, according to 8 Wall Street analysts, SI-BONE (SIBN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 75.00% of SIBN's total ratings.

What is SIBN's price target?

SI-BONE (SIBN) average price target is $18.5 with a range of $18 to $19, implying a 39.62% from its last price of $13.25. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will SI-BONE stock go up soon?

According to Wall Street analysts' prediction for SIBN stock, the company can go up by 39.62% (from the last price of $13.25 to the average price target of $18.5), up by 43.40% based on the highest stock price target, and up by 35.85% based on the lowest stock price target.

Can SI-BONE stock reach $20?

SIBN's average twelve months analyst stock price target of $18.5 does not support the claim that SI-BONE can reach $20 in the near future.

What are SI-BONE's analysts' financial forecasts?

SI-BONE's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $193.57M (high $196.67M, low $191.33M), average EBITDA is $-88.935M (high $-87.908M, low $-90.36M), average net income is $-25.796M (high $-23.65M, low $-27.692M), average SG&A $240.91M (high $244.77M, low $238.13M), and average EPS is $-0.618 (high $-0.567, low $-0.664). SIBN's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $225.73M (high $229.3M, low $223.48M), average EBITDA is $-104M (high $-103M, low $-105M), average net income is $-21.567M (high $-21.287M, low $-22.011M), average SG&A $280.94M (high $285.38M, low $278.13M), and average EPS is $-0.517 (high $-0.51, low $-0.528).

Did the SIBN's actual financial results beat the analysts' financial forecasts?

Based on SI-BONE's last annual report (Dec 2023), the company's revenue was $138.89M, beating the average analysts forecast of $130.68M by 6.28%. Apple's EBITDA was $-46.931M, missing the average prediction of $-60.689M by -22.67%. The company's net income was $-43.336M, missing the average estimation of $-57.561M by -24.71%. Apple's SG&A was $141.32M, missing the average forecast of $154.81M by -8.71%. Lastly, the company's EPS was $-0.0011, missing the average prediction of $-1.429 by -99.92%. In terms of the last quarterly report (Sep 2023), SI-BONE's revenue was $34.01M, beating the average analysts' forecast of $32.38M by 5.05%. The company's EBITDA was $-11.169M, missing the average prediction of $-14.877M by -24.92%. SI-BONE's net income was $-10.022M, missing the average estimation of $-14.286M by -29.85%. The company's SG&A was $34.22M, missing the average forecast of $40.3M by -15.07%. Lastly, the company's EPS was $-0.25, missing the average prediction of $-0.342 by -26.99%